Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment

BMC Cardiovascular Disorders
Erik HallengrenOlle Melander

Abstract

Growth hormone (GH) has been linked to cardiovascular disease but the exact mechanism of this association is still unclear. We here test if the fasting levels of GH are cross-sectionally associated with carotid intima media thickness (IMT) and whether treatment with fluvastatin affects the fasting level of GH. We examined the association between GH and IMT in 4425 individuals (aged 46-68 years) included in the baseline examination (1991-1994) of the Malmö Diet and Cancer cardiovascular cohort (MDC-CC). From that cohort we then studied 472 individuals (aged 50-70 years) who also participated (1994-1999) in the β-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS), a randomized, double blind, placebo-controlled, single-center clinical trial. Using multivariate linear regression models we related the change in GH-levels at 12 months compared with baseline to treatment with 40 mg fluvastatin once daily. In MDC-CC fasting values of GH exhibited a positive cross-sectional relation to the IMT at the carotid bulb independent of traditional cardiovascular risk factors (p = 0.002). In a gender-stratified analysis the correlation were significant for males (p = 0.005), but not for females (p = 0.09). Treatment with fluvastatin ...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M RudlingB Angelin
Jun 1, 1991·Clinical Endocrinology·S SainiC G Brook
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D W BilheimerJ L Goldstein
Jul 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·H OlivecronaB Angelin
Jan 1, 1993·Journal of Internal Medicine·G BerglundS A Larsson
Jul 3, 1998·The Journal of Clinical Investigation·C A JaffeA L Barkan
Aug 12, 1999·The Journal of Clinical Endocrinology and Metabolism·P C HindmarshC G Brook
May 23, 2001·Clinical Pharmacokinetics·C D Scripture, J A Pieper
Apr 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Margareta BramnertLeif Groop
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Patrick MaisonUNKNOWN Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
Jul 18, 2006·Pituitary·Sowmya SuryaAriel L Barkan
Dec 15, 2007·Metabolism: Clinical and Experimental·Maria Claudia Peixoto CenciMario Vaisman
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Feb 26, 2009·Endocrine Reviews·Niels Møller, Jens Otto Lunde Jørgensen
Oct 12, 2010·The Journal of Clinical Endocrinology and Metabolism·Johannes D VeldhuisSteven Pincus
Mar 15, 2012·European Journal of Endocrinology·Vanessa P AraujoRoberto Salvatori
Mar 5, 2013·Current Diabetes Reports·Mark R Goldstein, Luca Mascitelli
Mar 25, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cesare R Sirtori
May 6, 2014·Journal of Clinical Lipidology·Kevin C Maki The Diabetes Subpanel of the National Lipid Association Expert Panel
Jul 24, 2014·JACC. Cardiovascular Imaging·Tasneem Z Naqvi, Ming-Sum Lee
Oct 4, 2014·Journal of the American College of Cardiology·Erik HallengrenOlle Melander
Feb 1, 2015·The American Journal of Cardiology·Priscilla Y HsueDavid D Waters

❮ Previous
Next ❯

Methods Mentioned

BETA
sandwich immunoassay
hormone replacement therapy

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.